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Abstract
The evolution of disease or the progress of recovery of a patient is a complex process, which depends on many factors. A
quantitative description of this process in real-time by a single, clinically measurable parameter (biomarker) would be
helpful for early, informed and targeted treatment. Organ transplantation is an eminent case in which the evolution of the
post-operative clinical condition is highly dependent on the individual case. The quality of management and monitoring of
patients after kidney transplant often determines the long-term outcome of the graft. Using NMR spectra of blood samples,
taken at different time points from just before to a week after surgery, we have shown that a biomarker can be found that
quantitatively monitors the evolution of a clinical condition. We demonstrate that this is possible if the dynamics of the
process is considered explicitly: the biomarker is defined and determined as an optimal reaction coordinate that provides a
quantitatively accurate description of the stochastic recovery dynamics. The method, originally developed for the analysis of
protein folding dynamics, is rigorous, robust and general, i.e., it can be applied in principle to analyze any type of biological
dynamics. Such predictive biomarkers will promote improvement of long-term graft survival after renal transplantation, and
have potentially unlimited applications as diagnostic tools.
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Introduction
The responses of an individual to an infection, to pharmaco-
logical treatment or to surgery are examples of time-dependent
stochastic processes characterized by complex dynamics. An
increasing amount of time-resolved data is available reporting on
the unique chemical fingerprints that specific cellular processes
leave behind [1,2]. Metabolites, such as those found in blood or
urine, contain in principle a comprehensive picture (referred to as
the metabolome) of the evolution of a patients condition. While
such a picture is very complex and generally not insightful, the
time evolution of the metabolome of a patient contains crucial
information. Conventionally, a biomarker is sought by comparing
differences in the metabolic profiles between two states (e.g.
healthy and pathological) using unsupervised methods (such as
principal component analysis, PCA [3]) or supervised methods
(e.g., orthogonal projections to latent structures, OPLS [4] and
related [5]). However, if one is interested in time-related changes
to the metabolic profile, which are relevant to the pathological
state, for example in the monitoring of disease progression or
defining surrogate end points, the problem becomes more
complex. A number of other methods, sometimes borrowed from
other disciplines, have been proposed for analysis of time-resolved
metabolomic data [2]; they rely in general on previous knowledge,
either of the identity of the relevant metabolites and/or the
functional form of the time dependence of their concentrations.
When the underlying biochemical mechanism is itself unknown,
such methods are obviously not useful.
Disease dynamics, according to the systems biology point of
view, is more accurately described as dynamics of highly entangled
molecular networks, with disease being an emerging property of
the networks [6]. Adopting this view, we seek a biomarker, which
is a descriptor (function) of the networks states, rather than of a few
molecules. We assume that disease dynamics is a Markov
(memory-less) stochastic process, in which future behavior is
completely specified (in a probabilistic sense), by the current state
of an organism, e.g., the complex of genome, proteome,
metabolome, epigenome, age, environment, and whatever addi-
tional information may be required (hereafter the ‘‘configuration
space’’). Illustrative and enlightening is a recent study [1] where a
combination of genomic, transcriptomic, proteomic, metabolomic
and autoantibody profiles from a single individual was followed for
over a 14 month period. The analysis uncovered extensive
dynamics changes in diverse molecular components and biological
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pathways across healthy and disease states. In the case where the
dynamics is stochastic rather than deterministic, a single observed
trajectory is not sufficient for a complete description. In principle,
a Markov state model that gives a complete description of the
process can be constructed by observing various realizations of the
disease, and computing the transition probabilities between all
states. The model can be used to predict the properties of interest,
for example, the probability of a given outcome (e.g., full recovery)
after a certain time given an initial state. Such a straightforward
approach cannot be realized in practice. The amount of
information necessary to define exactly the state of an organism
is huge and difficult to identify; the statistics necessary to construct
the Markov state model grows exponentially with the dimension-
ality of the configuration space. Moreover, to be useful for
practitioners (e.g., for diagnostic purposes), the description of the
disease dynamics needs to be simplified. This can be done by
introducing one or a few variables (hereafter the ‘‘reaction
coordinate’’) that describe the properties of interest. Ideally, such
a simplified description should be as predictive as the Markov state
model previously described, i.e., the probability of a particular
clinical outcome calculated from the value of the variable should
closely approximate that computed based on the full Markov state
model. If such properties are satisfied we call the variable an
‘‘optimal reaction coordinate’’.
Determination of the optimal reaction coordinate
Here we present a general framework that allows us to
determine such an optimal coordinate or biomarker from
longitudinal cohort studies directly, without constructing the
Markov state model. The method was originally developed to
describe complex dynamics of protein folding [7–9]. Briefly, a
putative functional form of the reaction coordinate is assumed, for
example, a linear combination of features (here the metabolome
1H NMR spectra) that could describe the process. The approach is
invariant to the choice of the functional form and the set of
observables, provided they contain all the essential information
about the dynamics of the process. The coordinate is optimized
(trained) on a sample of trajectories, i.e., realizations of a complex
multidimensional dynamical process. This is achieved by choosing
the coordinate (e.g., the coefficients of the linear combination)
such that the cut based free energy profile associated with the
coordinate is the highest [7,10]. Namely, given an ensemble of N
trajectories ~Xj(t) (j~1,N) and a reaction coordinate functional
form y~R(~X ,~a) an ensemble of reaction coordinate trajectories is
constructed by projecting the multidimensional trajectories onto
the reaction coordinate yj(t)~R(~Xj(t),~a) (j~1,N). The optimal
reaction coordinate is found by optimizing the parameters ~a so
that the cut-based free energy profile FC(y) [7,8] is maximal.
FC(y)~{lnZC(y), where the partition function ZC(y) equals half
number of transitions (crossings) by the reaction coordinate time-
series through point y; here and below we set kBT~1. The
CFEP (FC ) unlike the conventional histogram based free energy
profile (FH ) is invariant to reaction coordinate rescaling,
insensitive to statistical noise and capable of detecting sub-
diffusion. Together they determine the coordinate dependent
diffusion coefficient D(x) and thus completely specify diffusive
dynamics [9]. One can maximize instead the generalized cut
based free energy profile FC,1(y)~{lnZC,1(y) where the
partition function ZC,1(y) takes into account each transition
through point y with weight equal to the transition distance; for a
Gaussian distribution of steps (i.e., diffusive dynamics) the two
optimality criteria are equivalent [10]. If the reaction coordinate
is a weighted sum of basis functions y~
P
k akXk, as used here,
the optimal values of the parameters (ai that maximize FC,1 can
be found analytically [10]).
In supervised optimization a coordinate that accurately
describes the dynamics of transition between two given end states
(e.g., healthy and disease) is determined. Incidentally, the
coordinate is the probability of full recovery, i.e., of ending up
in the ‘‘healthy’’ state rather than the ‘‘disease’’ state starting from
a current state. It is known as committor or folding probability in
protein folding studies [10,11]. If the two end states are separated
by the highest free energy barrier, the transition between them
corresponds to the slowest relaxation mode, and an eigenvector,
corresponding to the slowest mode is an optimal reaction
coordinate [10,12]. This coordinate can be determined in an
unsupervised way without explicit definition of end states.
Results/Discussion
The method outlined above (details given in Materials and
Methods) has been used to analyze the evolution of 1H NMR
spectra of the erythrocyte extracts of blood from 18 patients
undergoing kidney transplantation; for each patient up to nine
samples were taken before surgery and daily up to one week after.
The spectra were normalized to the total sum of the spectral
intensities and then coarse-grained with a bin size of 0.32 ppm.
The average intensity within each bin was logarithmically
transformed as Ik~log(10
6Ikz1). The reaction coordinate was
taken as a linear sum of the transformed average bin intensities:
y~
P
k akIk. The method to determine the optimal reaction
coordinate is robust: it was repeated with different transformation
(e.g., Ik~
ﬃﬃﬃﬃ
Ik
p
) or without transformation, with different bin sizes,
in a supervised way, all leading to virtually identical results. Note
however, as discussed below, a significant decrease of the bin size,
e.g., to 0.1 ppm, while leading to a slightly better description
results in over-fitting.
Independently of the NMR data, patients have been divided in
three classes based on a clinical assessment of the patients into
‘‘primary function’’ (PF), ‘‘delayed graft function’’ (DGF) and
‘‘acute rejection’’ (AR) with and without primary function.
Primary function was defined as immediate recovery of renal
function following surgery. Delayed graft function was defined as
the need for dialysis in the first week following transplantation.
The spectra for a single patient for nine different time points (a
‘‘trajectory’’), are shown in Fig. 1a. The trajectory for each patient
projected onto the first principal component (Fig. 1b) shows
individual variability but no separation between different classes of
Author Summary
The evolution of disease or the progress of recovery of a
patient is usually monitored by collecting physical param-
eters, which may be simply the body temperature for a
common cold or properties of tissue samples for e.g.,
cancer. Most often clinical decisions are taken based on
the current value or because of a sizable change of a
relevant parameter. As more advanced diagnostic tools
become available, and huge numbers of parameters can
be collected at short, frequent time intervals, two related
questions arise. The first is, which of the parameters
provides relevant information on the progress of disease
or recovery as opposed to noise? Is there more information
that can be obtained from the history of the evolution of
such parameters? Here we propose a novel approach that
leads, for the specific case of recovery from kidney
transplant, to a positive answer.
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patients, and no relevant information on the evolution of their
clinical conditions during the period in which the samples were
taken. The same is true if the trajectory is projected onto the first
few principal components.
Fig. 1c shows patients trajectories projected onto the optimal
reaction coordinate determined in the unsupervised way (the
second eigenvector). Trajectories categorized as PF are character-
ized by an evolution towards negative values of the coordinate;
those in the DGF cohort evolve towards positive values of the
coordinate. The time evolution of the AR patients cannot be
discerned within the timescale of the data collection. Importantly,
the clinical group to which each patient could be ascribed to is
apparent from about the second day after surgery, earlier than any
other clinical indicator, including invasive, though gold-standard,
biopsy. Note that separation between PF and DGF patients cannot
be due to dialysis, since dialysis was never performed in the first
two days after surgery.
The difference between the results of PCA (Fig. 1b) and of the
approach proposed here (Fig. 1c) can be understood as follows.
PCA (and other algorithms [10]) perform dimensionality reduction
with a focus on representation of the properties of the
configuration space. In particular, the PCA maximizes the
variability of configurations along the principal components. The
dynamical information contained in the temporal sequence of
congurations (trajectory) is ignored. By explicitly considering the
dynamics, our approach performs dimensionality reduction while
preserving and exploiting the dynamics of the process [10,13].
To demonstrate that the results are not affected by over fitting
(even though the analysis is unsupervised) the leave-one-out cross-
validation procedure was performed. In Fig. 1d every trajectory is
projected on the optimal reaction coordinate constructed without
the trajectory. All the trajectories are in good agreement with those
in Fig. 1c, and the prediction on the future evolution of each
trajectory (i.e., the fate of each patient) is identical. This confirms
that the constructed coordinate is robust and that the biomarker
can be used to follow up the evolution of the condition of a new
patient.
The leave-one-out cross-validation was also instrumental in
the choice of the bin size. Decreasing the bin size increases the
number of parameters and thus the flexibility of the coordinate;
while this leads to a slightly better separation, the cross-
validation test fails, a clear consequence of over fitting. Note
that, in principle, the possibility of over fitting, as well as the
optimality of the coordinate, could be established by comparing
the cut profiles computed with different time intervals [8,14] or
with other methods [15–17]. Alternatively, one may optimize
with an over fitting penalty [8], eliminating the need in the
manual choice of the bin size. Here we did not use such an
approach, because the trajectories are too short to be sampled
with larger intervals.
Figure 1. Unsupervised optimization. a) NMR spectra for blood extracts of a single patient, collected over nine time points. b) Patients
trajectories projected on the first principal component do not show any feature enabling us to separate the trajectories according to the clinical
assessment of the patients. The color indicates the final clinical classification of the patient: primary function patients are shown in black, delayed
graft function in red, and acute rejection in blue. c) Patients trajectories projected on the optimal reaction coordinate. d) Leave-one-out cross-
validation: every trajectory is projected on the optimal reaction coordinate constructed without that specific trajectory.
doi:10.1371/journal.pcbi.1003685.g001
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While the second eigenvector describes the transitions dynamics
over the highest barrier, it is possible that the third eigenvector,
which describes the second slowest process, would separate AR
cases from PF and/or DGF cases. However, this is not the case.
Among the many possible reasons why AR cases cannot be
discriminated from the other cases, one could be the insufficient
flexibility of the reaction coordinate due to the small number of
parameters. Increasing the number of parameters while avoiding
over fitting would require more trajectories (i.e., more patients)
than those available. To illustrate this fact we performed a
supervised analysis aimed at separating AR from PF and/or DGF
trajectories. Fig. 2a shows supervised optimization where PF
trajectories were terminated at 21 and AR and DGF trajectories
at 1. The results are virtually identical to those obtained by
unsupervised optimization reported in Fig. 1C. An attempt to
separate AR from PF and DGF with 0.32 ppm binning interval
did not produce meaningful results (Fig. 2b). Decrease of the size
of the binning interval to 0.1 ppm resulted in a more flexible
reaction coordinate, so that the supervised separation of AR from
PF and DGF become possible Fig. 2c. However, results of leave-
one-out cross-validation, shown in Fig. 2d illustrate that such small
binning interval leads to over fitting.
Having determined an optimal coordinate, the dynamics of
disease as a whole can be described as diffusion on the free energy
profile (Fig. 3) along the optimal coordinate. The latter has been
rescaled so that the diffusion coefficient equals unity. Two basins
(attractors) naturally emerge, one identifying the PF condition and
one for DGF and AR conditions together. Starting from the top of
the profile, a patients trajectory can fall either on the left (PF) or
Figure 2. Supervised optimisation. a) PF versus AR and DGF with binning interval of 0.32 ppm: the results are similar to the unsupervised
analysis Fig. 1C. b) AR versus PF and DGF with binning interval of 0.32 ppm: no clear separation between the classes. c) AR versus PF and DGF with
binning interval of 0.1 ppm: AR is separated from PF and DGF. d) leave one out cross validation of panel c: small binning interval of 0.1 ppm leads to
overfitting.
doi:10.1371/journal.pcbi.1003685.g002
Figure 3. The disease dynamics is described as diffusion on the
free energy landscape (black). The left and right basins correspond
to PF and DGF+AR states, respectively. Probability of the successful
outcome from current conditions P(x) computed from diffusion on the
free energy landscape (red line) and directly from the trajectories (the
blue vertical bar represents 95% confidence interval on the estimation).
doi:10.1371/journal.pcbi.1003685.g003
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the right (DGF+AR) basin. Fig. 3 shows the probability of full
recovery, i.e., of reaching the left basin (PF) before reaching the
right one (DGF+AR) starting from any value of the coordinate
(any condition before or after surgery) computed by assuming
diffusive dynamics on the free energy profile and directly from the
trajectories. Their agreement in combination with the cross-
validation (Fig. 1d) demonstrates the possibility to predict the
clinical outcome for patients not previously considered, meaning
that the optimal coordinate found is a good biomarker.
The linear coefficients of the optimal reaction coordinate (Fig. 4)
illustrate that the whole spectrum (metabolome) is important to
determine the optimal coordinate that provides a fine-grained
quantitatively accurate description of the dynamics. Indeed, the
largest weight is associated with the bin ranging from 3.84 to
4.16 ppm; this includes signals for creatinine. Creatinine is
currently used as a clinical marker in the assessment of renal
function and to monitor post-transplant recovery [18]; the trend in
the serum creatinine concentrations is more informative than
absolute values, but it is by no means a specific marker. Other
signals, e.g., at ca. 1 ppm/2 ppm and 1.4 ppm correspond to lipid
and lactate respectively; the signal for the CH of lactate is at
4.2 ppm. We note that while the identity of each of the metabolites
is undoubtedly interesting per se, their identities are not required for
the usage of the optimal coordinate for diagnostic purposes as a
biomarker.
In order to describe the specificity and sensitivity of a proposed
biomarker one commonly uses the ROC analysis, which describes
the trade-off between false positives and false negatives [19]. The
proposed approach differs from the conventional ones (e.g., the
PCA) by assuming that the disease dynamics is stochastic, which
makes an application of such analysis not straightforward. This
can be understood by considering a set of patients and a vector of
measurable characteristics (e.g., the NMR spectra) for i-th patient
denoted as Xi. Conventionally, one assumes that the true state of a
patient, denoted by Ti, can be unambiguously mapped (by a ‘‘gold
standard’’ test) onto two classes Ti~f0,1g, e.g., healthy and
diseased. And that this mapping is deterministic, i.e., that if
Xi~Xj , then Ti~Tj . A biomarker is then a binary functionM(X)
from Xi onto f0,1g which best approximates Ti. Cases where
M(Xi)=Ti correspond to the two possible types of errors - false
positive and false negative. The former, for example, corresponds
to the fraction of cases whereM(Xi)~1, while Ti~0. Since Ti are
determined by a ‘‘gold standard’’ test, the biomarker function is
assumed to be the sole source of errors.
The proposed approach assumes that the current state of a
patient Ti is related to the two terminal states f0,1g, where the
patient will end up eventually, only probabilistically. Identical
patients with identical conditions undergoing identical treatment
(i.e., Xi~X) will end up in different terminal states 1 and 0 with
probabilities of p and 1{p, respectively. Thus knowing the
terminal state does not allow one to determine the true value of the
current state Ti, i.e., a ‘‘gold standard’’ test and stochastic
dynamics are incompatible. Correspondingly, the purpose of a
biomarker is not to approximate the terminal states but rather to
approximate the probability p(Xi) of ending up in one of the two
end states.
A way to asses the accuracy of such a biomarker is to judge how
accurately it reproduces that probability, e.g., Fig. 3. The
classification process is analogous to the Bernoulli trial of a binary
random variable that accepts 1 with probability pi~p(Xi). To
determine the probability p(Xi) of ending up in the terminal state
1, starting from Xi, one needs to repeat ‘‘the experiment’’ a
number of times starting from the same conditions Xi (in
particular, the same patient) and count the fraction of events
ending up in 1. Such a direct approach is clearly unrealistic. An
alternative is to combine the states Xi with similar p(Xi)&p and
determine p from such an ensemble of states, as have been done in
Fig. 3.
Conclusion
We have shown that the dynamics of recovery from kidney
transplant can be quantitatively described as diffusion on a free
energy profile, which is a function of a measurable biomarker.
Such a biomarker can be determined in an (un)supervised way
from longitudinal cohort studies (patient trajectories), which is
optimal in the sense that it is able to discriminate where each
patient is on a free energy profile. In particular, the probability of
rapid recovery (primary function) can be used to devise optimal
treatment. Such an approach is general and can be useful to
develop optimal biomarkers for diseases that develop slowly and in
a complicated way depending on many factors, or unknown
unknowns, such as aging [20], cancer [21,22] and psychological
disorders [23].
Materials and Methods
Ethics statement
Approval was given by the regional ethics approval committee
approval number REC Ref: 07/H1306/129
The cut-based free energy profiles
The partition function of the cut-based free energy profile ZC,r
at point y equals half the sum of the distances of those trajectory
steps that go through point y [14]. More precisely,
ZC,r(y)~
1=2
X
i
jx(iDtzDt){x(iDt)jrH½{(x(iDtzDt){y)(x(iDt){y),
where H(x) is the Heaviside step function and x(iDt) is the reaction
coordinate time series sampled with time interval Dt. The cut free
energy profile is defined as FC,r(y)=kT~{lnZC,r(y) and
FC~FC,0; here we assume that kT~1.
The optimal coordinate is defined as the one with the highest
cut profiles (lowest partition function). The justification of the
Figure 4. Linear coefficients of the optimal reaction coordinate
y~
P
k akIk, where Ik is the logarithm of the intensity of NMR
spectra in bin k.
doi:10.1371/journal.pcbi.1003685.g004
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optimization criteria can be summarized as follows (for the details
see the cited references). It can be shown that minimum ofÐ
ZC,1(y)dy, with constrains y(A)~0 and y(B)~1, is attained
when the reaction coordinate y equals the pfold coordinate - an
optimal coordinate [10]. Correspondingly, a sub-optimal coordi-
nate with a lower value of the cut profile, has the mean square
displacement which grows slower then linear with time [14]. The
latter is an indication that dynamics is not diffusive and that non-
Markovain memory effects are at play. Another manifestation of a
sub-optimal coordinate, is that it has lower free energy barriers
and thus a faster kinetics. The kinetics along the coordinate with
the highest cut profile is the slowest [9,14].
Supervised optimization
Optimization of the reaction coordinate can be performed in a
supervised or unsupervised manner. In supervised optimization a
coordinate that accurately describes the dynamics of transition
between two given end states (e.g., healthy and disease) is
determined. Incidentally, the optimal coordinate is the probability
of full recovery, i.e., of ending up in the ‘‘healthy’’ state rather than
the ‘‘disease’’ state starting from a current state. The optimization
is constrained by fixing the value for the coordinate for the two
state y(A)~0 and y(B)~1 [10]. If the reaction coordinate is a
weighted sum of basis functions y~R(~X ,~a)~
P
k akrk(
~X ),
boundary conditions are given as yi0~
P
k akrk(
~X (i0Dt))~0
and yi1~
P
k akrk(
~X (i1Dt))~1 where i0 and i1 index the points
which belong to A and B states, respectively. The optimal weights
(ai) which give constrained maximum to
Ð
ZC,1(y)dy can be found
analytically [10]. Here we specified the constrains in the following
way, which resulted in a more flexible coordinate. Instead of
assuming that each trajectory ends at either 0 or 1, we assumed
that each trajectory is constrained to end with either 0 or 1 (in
other words a trajectory reaches an end state on the following day).
In this case the optimal weights are found by minimizingÐ
ZC,1(y)dy*
P
i,j ½yj(iDtzDt){yj(iDt)2, which equals
X
j~1,N
X
i~1,tj{1
X
k
akrk(~Xj(iDtzDt)){akrk(~Xj(iDt))
" #2
z
X
j~1,N
bj{
X
k
akrk(~Xj(tj))
" #2
,
where i,j,k are indexes that refer to time frame, trajectory and
basis function, respectively; the second term of the functional
describes the boundary condition with bj equal 0 or 1 for
trajectories connected to 0 or 1, respectively. The optimal
parameters are found by solving the corresponding system of
linear equations L=Lak
Ð
ZC,1(y)dy~0. To facilitate the visual
comparison with the unsupervised results bj~0 where changed to
bj~{1, which results in a shift and change of scale of the optimal
coordinate.
Unsupervised optimization
In unsupervised optimization the determined coordinate
describes the slowest relaxation mode (the second eigenvector) of
the stochastic dynamics [10]. If the two states (A and B) are
separated by the highest barrier, so the slowest relaxation rate
corresponds to the transition dynamics between the states, the
second eigenvector reaction coordinate approximates the folding
probability (the probability of full recovery here) reaction
coordinate in the transition state region - the most important part
for the description of the transition dynamics [10,12]. The
eigenvectors can be found by minimizing I~
Ð
ZC,1(y)dy*P
i,j ½yj(iDtzDt){yj(iDt)2 under constraint
P
i,j y
2
j (iDt)~1
[10]. Due to the constraint, the optimization function simplifies
to the auto-correlation function. If reaction coordinate is a
weighted sum of basis functions, the optimal weights can be
found analytically. They are the solution of the generalized
eigenvalue problem [10].
Determination of the equilibrium free energy profile and
the probability of successful outcome
The free energy profile that describes the disease dynamics
cannot be determined from the patients trajectory simply by
computing the cut based (or histogram) free energy profiles
because the trajectories are not at equilibrium. The procedure
described in Ref [13] was employed. Briefly, assuming diffusive
dynamics, the equilibrium free energy profile can be computed
from the steady state (non-equilibrium) probability distribution Pss
as
F (x)~{lnPss(x){
ðx J(x)dx
D(x)Pss(x)
:
Using Pss(x)~ZH (x), J(x)Dt~Z
z
C (x){Z
{
C (x) and
D(x)~(ZC=ZH )
2p=Dt, one obtains
F (x)~{lnZH (x){
ðx (ZzC (x){Z{C (x))ZH (x)dx
pZ2C(x)
,
where ZzC (x) and Z
{
C (x) are the cut profiles that measure flux in
positive and negative direction, respectively.
Note that the method for determining the optimal reaction
coordinate was originally derived for equilibrium dynamics; an
extension of the framework to non-equilibrium dynamics has been
suggested recently [24]. Here we assume that while non-
equilibrium sampling affects populations, its main effect on the
optimization procedure is in altering the contribution (weight) of
the different regions to the optimization functional
Ð
ZC,1(x)dx
and can be neglected.
The probability of ‘‘full recovery’’ (the folding probability) was
computed from the free energy profile as
p(x)~
Ð b
x
eF (x)=D(x)dxÐ b
a
eF (x)=D(x)dx
The success probability with 95% confidence interval were
estimated from the trajectories by ‘‘add two successes and two
failures’’ approach [25] as p^i+2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
p^i(1{p^i)=(n
l
izn
r
iz4)
q
, where
p^i~(n
l
iz2)=(n
l
izn
r
iz4) and n
l
i and n
r
i are the numbers of
trajectories visiting bin i ended up in left or right half of the profile,
respectively [26].
Acquisition of NMR spectra
1H NMR spectra were obtained for the water soluble
components [27] of erythrocytes taken from 18 kidney transplant
patients (up to 9 time points from pre-op to 7 days after surgery).
One-dimensional 1H NMR spectra were measured at
499.97 MHz on a Varian Unity Inova 500 spectrometer at
20uC, using a standard PRESAT pulse sequence. For all samples a
relaxation delay of ca. 9 s (three times the longest T1) was applied
Optimal Reaction Coordinate as a Biomarker
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between scans to allow the spins to fully relax, with 256 transients
collected into 16384 data points and a spectral width of 6000 Hz.
An exponential line broadening of 0.5 Hz was applied to each
free induction decay (FID) and zero filling to 32768 points was
carried out, followed by Fourier transformation. Phase and
baseline corrections were carried out using ACD/Labs 12.0
(Advanced Chemistry Development Inc., Toronto, Canada) and
chemical shifts were referenced to the lactate doublet at 1.33 ppm.
Clinical assessment of patients
Independently of the NMR data, patients have been divided in
three classes based on a clinical assessment of the patients into
primary function (PF), delayed graft function (DGF) and acute
rejection (AR) with and without primary function. Primary
function was defined as immediate recovery of renal function.
Delayed graft function was defined as the need for dialysis in the
first week following transplantation. Diagnosis of acute rejection
was conducted on the basis of biopsy and histological findings.
Dialysis was performed on day 5 to patient 4, day 2 to patient 7,
day 4 to patient 9, day 7 to patient 17 and day 6 to patient 18. All
biopsies were conducted between 6 and 9 days following
transplantation. Nine patients had immediate primary function,
five patients had delayed graft function and four patients had acute
rejection. All but one transplant were eventually successful: in
addition to acute rejection, patient 14 also suffered from renal
artery stenosis, and the graft was ultimately removed. The
immunosuppressive regime and induction agents were the same
across the cohort.
Supporting Information
Data S1. NMR Spectra of patients.
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